Bill Varie/Getty Images About 2.8 million people globally live with multiple sclerosis (MS). Two-thirds of people with MS move to a worsened state of the disease called secondary progressive MS. Researchers from the University of Genoa found hematopoietic stem cell transplants help delay disability longer in people with active secondary progressive MS than some MS medications....
